At close: December 13 at 4:00:01 PM EST
After hours: December 13 at 7:33:33 PM EST
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 2 | 1 | 2 | 2 |
| Avg. Estimate | -0.23 | -0.31 | -1.81 | -0.66 |
| Low Estimate | -0.27 | -0.31 | -1.88 | -1.01 |
| High Estimate | -0.18 | -0.31 | -1.75 | -0.31 |
| Year Ago EPS | -0.53 | -0.27 | -1.96 | -1.81 |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 6 | 4 | 7 | 7 |
| Avg. Estimate | 2.92M | 1.4M | 18.14M | 7.11M |
| Low Estimate | -- | -- | 15.7M | -- |
| High Estimate | 8M | 4.1M | 23.26M | 21.67M |
| Year Ago Sales | 2.88M | 4.06M | 5.9M | 18.14M |
| Sales Growth (year/est) | 1.35% | -65.51% | 207.23% | -60.81% |
Earnings History
| Currency in USD | 12/31/2023 | 3/31/2024 | 6/30/2024 | 9/30/2024 |
|---|---|---|---|---|
| EPS Est. | -0.45 | -0.4 | -0.2 | -0.28 |
| EPS Actual | -0.53 | -0.27 | -0.31 | -0.17 |
| Difference | -0.08 | 0.14 | -0.11 | 0.1 |
| Surprise % | -17.97% | 33.81% | -52.99% | 37.62% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.23 | -0.31 | -1.81 | -0.66 |
| 7 Days Ago | -0.27 | -0.28 | -1.75 | -0.72 |
| 30 Days Ago | -0.28 | -0.26 | -1.93 | -0.77 |
| 60 Days Ago | -0.23 | -0.26 | -1.89 | -0.64 |
| 90 Days Ago | -0.23 | -0.26 | -1.89 | -0.64 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | 1 | -- | 1 |
| Up Last 30 Days | -- | 1 | -- | 1 |
| Down Last 7 Days | -- | -- | 1 | -- |
| Down Last 30 Days | -- | -- | 2 | 1 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| GBIO | 57.46% | -16.94% | 7.42% | 63.56% |
| S&P 500 | 5.00% | 12.00% | 2.10% | 12.20% |
Upgrades & Downgrades
| Reiterates | Needham: Buy to Buy | 10/23/2024 |
| Reiterates | Wedbush: Outperform to Outperform | 8/8/2024 |
| Reiterates | Needham: Buy to Buy | 8/8/2024 |
| Reiterates | Needham: Buy to Buy | 5/14/2024 |
| Reiterates | Wedbush: Outperform to Outperform | 5/14/2024 |
| Reiterates | Needham: Buy to Buy | 4/10/2024 |
Related Tickers
PMVP PMV Pharmaceuticals, Inc.
1.5800
0.00%
ALXO ALX Oncology Holdings Inc.
1.4500
+2.11%
ORIC ORIC Pharmaceuticals, Inc.
8.52
+1.07%
NKTX Nkarta, Inc.
2.3400
+2.18%
ANNX Annexon, Inc.
4.4400
-1.55%
RLMD Relmada Therapeutics, Inc.
0.3670
-0.81%
CGEM Cullinan Therapeutics, Inc.
11.75
-3.69%
SNSE Sensei Biotherapeutics, Inc.
0.4400
+2.30%
SPRB Spruce Biosciences, Inc.
0.3832
-1.01%
PASG Passage Bio, Inc.
0.7590
-3.08%